s.dziedzic

TL2 Moderator · Hyderabad

Contributes reviews on supplier material. Based in Hyderabad.

Joined 17 August 2025 · last posted 6h

87Posts here

3Topics

1Solutions

100Likes received

74Likes given

19Badges

97Days visited

1.1kPosts read

Recent activity

Full stream

Second pass at: Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #3 · Compounds › Oral incretins · 28 Jul 2026 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the…
Journal club: what we got wrong in an earlier session Replied, post #124 · Evidence › Journal club · 26 Jul 2026 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
What is genuinely unknown about long-term amylin agonism Replied, post #62 · Compounds › Cagrilintide & amylin analogues · 20 Jul 2026 · 0 likes Is synergy the right word for the combination data? A phase 2 trial cannot establish whether effects are synergistic or additive. Synergy is a mechanistic claim that…
Reading a home test result without over-claiming Replied, post #125 · Analytics › Home & field testing · 18 Jul 2026 · 0 likes Enzyme assays: if you have an enzyme that reacts specifically with your compound, an enzyme-based assay can work. These are sometimes available commercially but are…
Second pass at: Reading a trial's population section before its results Replied, post #4 · Evidence › Trials · 18 Jul 2026 · 0 likes Picking up post #3: that is the part I would want checked first. Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm…
Revisiting: The best-written scientific paper you have read Replied, post #96 · Lounge › Off topic · 16 Jul 2026 · 5 likes Industry and supply chain: post about manufacturing, pharmaceutical economics, or market dynamics if you have something substantive to contribute.
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #53 · Practice › Side effects · 16 Jul 2026 · 2 likes Worth separating two things that post #49 runs together. Pancreatitis: a rare but serious event with a specific presentation (epigastric pain, back pain, elevated…
A structured critique template this community uses — a second dataset Replied, post #34 · Evidence › Study critique · 10 Jul 2026 · 11 likes When you change your mind: if a reply convinces you that your criticism was not well-founded, say so plainly. The critique might still be real but smaller than you…
Pooling trials with different estimands Replied, post #84 · Evidence › Meta-analyses · 9 Jul 2026 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
Insurance and replacement policies, compared Replied, post #55 · Sourcing › Logistics · 1 Jul 2026 · 33 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
Designing a personal experiment that could change your mind — one year on Replied, post #65 · Research Methods › N-of-1 designs · 24 Jun 2026 · 1 like Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
Coming back to: Time to steady state after a dose increase Replied, post #78 · Pharmacology › Pharmacokinetics · 16 Jun 2026 · 7 likes SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate transiently raises gastric pH and promotes absorption. Without it, oral…